Logo image of CWD

CALIBERCOS INC-CL A (CWD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CWD - US13000T6047 - Common Stock

1.7 USD
+0.01 (+0.59%)
Last: 12/16/2025, 2:56:55 PM
Fundamental Rating

2

Taking everything into account, CWD scores 2 out of 10 in our fundamental rating. CWD was compared to 237 industry peers in the Capital Markets industry. CWD has a bad profitability rating. Also its financial health evaluation is rather negative. CWD has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CWD has reported negative net income.
CWD had a negative operating cash flow in the past year.
CWD had negative earnings in 4 of the past 5 years.
CWD had negative operating cash flow in 4 of the past 5 years.
CWD Yearly Net Income VS EBIT VS OCF VS FCFCWD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -10M -20M

1.2 Ratios

The Return On Assets of CWD (-30.73%) is worse than 89.03% of its industry peers.
CWD's Return On Equity of -606.55% is on the low side compared to the rest of the industry. CWD is outperformed by 92.41% of its industry peers.
Industry RankSector Rank
ROA -30.73%
ROE -606.55%
ROIC N/A
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CWD Yearly ROA, ROE, ROICCWD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -200 -400

1.3 Margins

CWD does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CWD Yearly Profit, Operating, Gross MarginsCWD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

Compared to 1 year ago, CWD has more shares outstanding
Compared to 5 years ago, CWD has more shares outstanding
CWD has a worse debt/assets ratio than last year.
CWD Yearly Shares OutstandingCWD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CWD Yearly Total Debt VS Total AssetsCWD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of -1.16, we must say that CWD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -1.16, CWD is not doing good in the industry: 84.39% of the companies in the same industry are doing better.
CWD has a Debt/Equity ratio of 13.94. This is a high value indicating a heavy dependency on external financing.
CWD has a Debt to Equity ratio of 13.94. This is amonst the worse of the industry: CWD underperforms 91.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 13.94
Debt/FCF N/A
Altman-Z -1.16
ROIC/WACCN/A
WACCN/A
CWD Yearly LT Debt VS Equity VS FCFCWD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 1.47 indicates that CWD should not have too much problems paying its short term obligations.
CWD's Current ratio of 1.47 is fine compared to the rest of the industry. CWD outperforms 67.09% of its industry peers.
CWD has a Quick Ratio of 1.47. This is a normal value and indicates that CWD is financially healthy and should not expect problems in meeting its short term obligations.
CWD has a better Quick ratio (1.47) than 67.51% of its industry peers.
Industry RankSector Rank
Current Ratio 1.47
Quick Ratio 1.47
CWD Yearly Current Assets VS Current LiabilitesCWD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for CWD have decreased by -3.03% in the last year.
CWD shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -62.85%.
Measured over the past years, CWD shows a decrease in Revenue. The Revenue has been decreasing by -8.07% on average per year.
EPS 1Y (TTM)-3.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-795%
Revenue 1Y (TTM)-62.85%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-67.83%

3.2 Future

CWD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.25% yearly.
CWD is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.62% yearly.
EPS Next Y77.39%
EPS Next 2Y42.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-38.97%
Revenue Next 2Y-12.03%
Revenue Next 3Y-2.62%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CWD Yearly Revenue VS EstimatesCWD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 20M 40M 60M 80M
CWD Yearly EPS VS EstimatesCWD Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 -5 -10 -15

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CWD. In the last year negative earnings were reported.
CWD is valuated cheaply with a Price/Forward Earnings ratio of 4.01.
Based on the Price/Forward Earnings ratio, CWD is valued cheaply inside the industry as 96.20% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 23.78. CWD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.01
CWD Price Earnings VS Forward Price EarningsCWD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CWD Per share dataCWD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

CWD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CWD's earnings are expected to grow with 42.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.25%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

CWD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CALIBERCOS INC-CL A

NASDAQ:CWD (12/16/2025, 2:56:55 PM)

1.7

+0.01 (+0.59%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-13 2025-11-13/amc
Earnings (Next)03-30 2026-03-30/amc
Inst Owners0.51%
Inst Owner Change-4.36%
Ins Owners4.76%
Ins Owner Change0%
Market Cap11.07M
Revenue(TTM)24.66M
Net Income(TTM)-25.37M
Analysts80
Price Target7.14 (320%)
Short Float %2.5%
Short Ratio0.85
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-333.6%
Min EPS beat(2)-337.12%
Max EPS beat(2)-330.07%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-17.48%
Min Revenue beat(2)-19.63%
Max Revenue beat(2)-15.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.82%
Min Revenue beat(4)-19.63%
Max Revenue beat(4)28.56%
Revenue beat(8)6
Avg Revenue beat(8)88.02%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-81.82%
PT rev (3m)-81.58%
EPS NQ rev (1m)0%
EPS NQ rev (3m)70.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-5.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-10%
Revenue NY rev (3m)-10%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.01
P/S 0.45
P/FCF N/A
P/OCF N/A
P/B 2.65
P/tB 2.65
EV/EBITDA N/A
EPS(TTM)-18
EYN/A
EPS(NY)0.42
Fwd EY24.95%
FCF(TTM)-1.04
FCFYN/A
OCF(TTM)-1.04
OCFYN/A
SpS3.79
BVpS0.64
TBVpS0.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -30.73%
ROE -606.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-7.38%
ROA(5y)-4.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 13.94
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.47
Quick Ratio 1.47
Altman-Z -1.16
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-795%
EPS Next Y77.39%
EPS Next 2Y42.25%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-62.85%
Revenue growth 3Y-3.01%
Revenue growth 5Y-8.07%
Sales Q2Q%-67.83%
Revenue Next Year-38.97%
Revenue Next 2Y-12.03%
Revenue Next 3Y-2.62%
Revenue Next 5YN/A
EBIT growth 1Y20.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year96.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y54.11%
FCF growth 3YN/A
FCF growth 5Y-35.8%
OCF growth 1Y54.11%
OCF growth 3YN/A
OCF growth 5Y-35.8%

CALIBERCOS INC-CL A / CWD FAQ

Can you provide the ChartMill fundamental rating for CALIBERCOS INC-CL A?

ChartMill assigns a fundamental rating of 2 / 10 to CWD.


What is the valuation status for CWD stock?

ChartMill assigns a valuation rating of 4 / 10 to CALIBERCOS INC-CL A (CWD). This can be considered as Fairly Valued.


How profitable is CALIBERCOS INC-CL A (CWD) stock?

CALIBERCOS INC-CL A (CWD) has a profitability rating of 0 / 10.


What is the financial health of CALIBERCOS INC-CL A (CWD) stock?

The financial health rating of CALIBERCOS INC-CL A (CWD) is 2 / 10.